Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MVC-COV1901(Saline)
BIOLOGICAL
2 trials
Sponsors
Medigen Vaccine Biologics Corp.
Conditions
Covid19 Vaccine
Phase 2
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
Completed
NCT04695652
Medigen Vaccine Biologics Corp.
Covid19 Vaccine
Start: 2020-12-30
End: 2021-10-29
Updated: 2022-01-31
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents
Completed
NCT04951388
Medigen Vaccine Biologics Corp.
Covid19 Vaccine
Start: 2021-07-22
End: 2022-03-21
Updated: 2022-04-20
Related Papers
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
Vaccines
2022-12-21
6 citations
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial
npj Vaccines
2022-12-16
14 citations
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.
2021-10-13
110 citations
Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blind, Randomised, Placebo-Controlled Phase 2 Trial
TUScholarShare (Temple University)
2021-08-08
1 citations
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study.
2021-06-26
51 citations